Form 4 for CAH Cardinal Health
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-09 · accession 0000721371-22-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-11 | 2022-08-09 | CAH | CRAWFORD VICTOR L. | CEO, Pharmaceutical Segment | A - Grant | $0.00 | +36.5K | 118.5K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-08-09 | A | A | 36,536 | $0.00 | 118,501 | D | — | — | (F1) Reflects performance share units that will settle on August 15, 2022. |